The EU passes the AI Act and its implications for digital medicine are unclear
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
On 13 March 2024, the much-anticipated AI Act was passed by the EU parliament and will soon be adopted as EU law. It will apply new requirements for developers and deployers of AI-enabled digital health tools (DHTs), including for a defined class of high-risk AI systems and for general-purpose AI. Although the text of the law is available, complete in all but the final checks of legal wording much is still not known about how the AI Act will affect the digital health landscape in the EU and beyond. The wording of many aspects of the Act is ambiguous, and often high-level objectives are stated, with the detail to come later in associated guidance, standards, and member state law and policy. It is also uncertain how the Act will intersect with pre-existing sector-specific legislation for medical AI. There are future steps in the legislative process that can clarify ambiguity, including standards, guidelines, and implementing laws, and the author remains optimistic the EU will get the implementation right.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Derraz, B., Breda, G., Kaempf, C., Baenke, F., Cotte, F., Reiche, K., Köhl, U., Kather, J. N., Eskenazy, D., & Gilbert, S. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00517-w · Cited by 94
Self-citation
Cited by
Lekadir, K., Frangi, A. F., Porras, A. R., Glocker, B., Cintas, C., Langlotz, C. P., Weicken, E., Asselbergs, F. W., Prior, F., Collins, G. S., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081554 · Cited by 957
Large language models for structured reporting in radiology: past, present, and future
Busch, F., Hoffmann, L., dos Santos, D. P., Makowski, M. R., Saba, L., Prucker, P., Hadamitzky, M., Navab, N., Kather, J. N., Truhn, D., et al. (2024) · European Radiology · doi:10.1007/s00330-024-11107-6 · Cited by 134
“In Europe, on the other hand, the fi rst legally binding framework for AI became effective with the adoption of the AI Act of the European Union (EU) on March 13, 2024 [64].”
The ethical requirement of explainability for AI-DSS in healthcare: a systematic review of reasons
Freyer, N., Groß, D., & Lipprandt, M. (2024) · BMC Medical Ethics · doi:10.1186/s12910-024-01103-2 · Cited by 67
“The AIA defines all medical devices as defined in the medical device regulation or the in-vitro medical device regulation as ‘high-risk’ systems (cf. Annex II of the AIA [6] and Gilbert’s analysis [9]).”
BackgroundPammi, M., Shah, P. S., Yang, L. K., Hagan, J., Aghaeepour, N., & Neu, J. (2025) · The Lancet Digital Health · doi:10.1016/j.landig.2025.01.007 · Cited by 60
“35 The new law is applicable to the developers and deployers of general-purpose AI systems, to AI systems including AI enabled digital health tools, and to high-risk AI systems, including digital health tools in a staggered timeline.”
Sarantopoulos, A., Mastori Kourmpani, C., Yokarasa, A. L., Makamanzi, C., Antoniou, P., Spernovasilis, N., & Tsioutis, C. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9100228 · Cited by 40
Metadata
- Authors
- Gilbert, S.
- Venue
- npj Digital Medicine
- Published
- 2024-05-22
- Volume
- 7
- Issue
- 1
- Pages
- 135-135
- ISSN
- 2398-6352 (ISSN-L)
- OpenAlex
- W4398202924
- Cited by
- 68
- References
- 1
- FWCI
- 178.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The EU passes the AI Act and its implications for digital medicine are unclear. https://app.cochat.ai/papers/10.1038/s41746-024-01116-6
- The paper
- Gilbert, S. (2024). The EU passes the AI Act and its implications for digital medicine are unclear. npj Digital Medicine. https://doi.org/10.1038/s41746-024-01116-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.